Skip to main content
Clinical Trials/NL-OMON56963
NL-OMON56963
Not yet recruiting
Not Applicable

Assessment of mitochondrial function measurements in Parkinson's disease patients and healthy volunteers to identify new potential biomarkers. - Mitochondrial function measurements in Parkinson*s disease patients

Centre for Human Drug Research0 sites32 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's disease
Sponsor
Centre for Human Drug Research
Enrollment
32
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers:
  • 1\. Adult male or female subjects 50 years of age or older, inclusive.
  • 2\. Healthy status as defined by absence of evidence of any significant active
  • acute or chronic disease or illness following a detailed medical and surgical
  • history, a complete physical and neurological examination including vital
  • signs, 12\-lead ECG, haematology, blood chemistry and urinalysis, as judged by
  • the investigator,
  • 3\. Body mass index (BMI) between 18\-32 kg/m2, inclusive.
  • 4\. Evidence of a personally signed and witnessed informed consent document
  • indicating that the subject has been informed of all pertinent aspects of the

Exclusion Criteria

  • Healthy subjects
  • 1\. Legal incapacity or inability to understand or comply with the requirements
  • of the study
  • 2\. Clinically significant findings as determined by medical history taking,
  • physical examination, fundoscopy, ECG, laboratory findings and vital signs
  • 3\. Female participant is pregnant or planning to become pregnant during the
  • 4\. Have a urine drug screen detecting illicit drug(s) of abuse (morphine,
  • benzodiazepines, cocaine, amphetamine, THC) or positive alcohol breath test at
  • screening. A positive urine drug screen for prescribed medication is allowed at
  • the discretion of the investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials